Compare GRRR & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRRR | DERM |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.6M | 190.3M |
| IPO Year | 2022 | 2021 |
| Metric | GRRR | DERM |
|---|---|---|
| Price | $6.86 | $3.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $32.83 | $12.75 |
| AVG Volume (30 Days) | ★ 1.0M | 203.8K |
| Earning Date | 11-19-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.72 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $61,858,000.00 |
| Revenue This Year | $103.71 | $18.51 |
| Revenue Next Year | $178.41 | $39.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.20 |
| 52 Week Low | $6.20 | $3.40 |
| 52 Week High | $23.49 | $9.56 |
| Indicator | GRRR | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 30.32 |
| Support Level | $6.65 | N/A |
| Resistance Level | $8.74 | $5.49 |
| Average True Range (ATR) | 0.79 | 0.36 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 25.98 | 16.75 |
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments. Its expertise lies in revolutionizing urban operations, enhancing security, and optimizing digital transformation. It delivers pioneering products that integrate AI, deep learning, and edge computing to advance intelligent video surveillance, facial recognition, license plate recognition, post-event analytics, cybersecurity, and network intelligence.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.